Sort
82,697 grants matching “vaccine development”
University of Washington Vaccine and Treatment Evaluation Unit
$2,527,789Anna Wald · University Of Washington · UM1 · FY2025 · AI
Protective immunity following dengue virus natural infections and vaccination
$2,527,162Eva Harris · University Of California Berkeley · P01 · FY2024 · AI
Protective immunity following dengue virus natural infections and vaccination
$2,527,162Eva Harris · University Of California Berkeley · P01 · FY2023 · AI
Project-002
$2,526,880John P Rotrosen · New York University School Of Medicine · UG1 · FY2016 · DA
Epitope-targeted Vaccines for HIV-1 Prevention
$2,525,880Xiangpeng Kong · New York University School Of Medicine · P01 · FY2017 · AI
Tissue compartmentalization of human lymphocytes
$2,525,606Donna L Farber · Columbia University Health Sciences · P01 · FY2013 · AI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
$2,525,443Christopher Parks · International Aids Vaccine Initiative · P01 · FY2016 · AI
Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers
$2,524,997John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2012 · AI
Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers
$2,524,997John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2013 · AI
Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers
$2,524,995John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2014 · AI
Providence/Boston Center for AIDS Research (CFAR)
$2,524,686Susan Cu-Uvin · Miriam Hospital · P30 · FY2019 · AI
Understanding Papillomavirus Virion Proteins and Vaccines
$2,524,474John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Modeling affinity maturation at molecular resolution
$2,524,199Thomas B Kepler · Boston University Medical Campus · U19 · FY2018 · AI
Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
$2,523,410Xiaoying Shen · Duke University · N01 · FY2025 · AI
The Immunobiology of Marrow Allografts for Leukemia
$2,522,446Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
Influenza Viral Pathogenesis
$2,521,394Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
CONSOLIDATED BASIC CANCER RESEARCH PROGRAM
$2,520,644Russel E. Kaufman · Wistar Institute · P30 · FY2007 · CA
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA VACCINE RESEARCH ACTIVITIES
$2,520,286Andrew S. Pekosz · Johns Hopkins University · N01 · FY2023 · AI
DOMESTIC MASTER CONTRACT FOR HIV VACCINE EFFICACY TRIALS
$2,520,000Abt Associates, Inc. · N01 · FY2000 · AI
Host and Pathogen Evolution in Lassa Fever
$2,520,000Pardis Christine Sabeti · Harvard University · DP2 · FY2010 · OD
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
$2,520,000Louis J. Picker · Oregon Health & Science University · U19 · FY2017 · AI
Naturally-Acquired and Vaccine-Mediated Immunity to Leptospirosis
$2,519,964Albert Icksang Ko · Yale University · R01 · FY2017 · AI
Southeastern Sexually Transmitted Infections Cooperative Research Center
$2,519,556Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U19 · FY2010 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$2,518,885Jeffrey Lennox · Emory University · UM1 · FY2014 · AI
Adoptive Cell Transfer Immunotherapy of Cancer
$2,518,659Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA